Fast-fashion recycling: how ‘the castoff capital of the world’ is making Indian factory workers sick

The GuardianTuesday, October 7, 2025 at 4:00:32 AM
Fast-fashion recycling: how ‘the castoff capital of the world’ is making Indian factory workers sick
In Panipat, known as the 'castoff capital of the world', alarming reports of lung disease, skin conditions, and cancer are emerging among factory workers involved in textile recycling. The city processes a staggering 1 million tonnes of textile waste annually, and the working conditions are dire, with air thick with harmful lint. This situation not only highlights the health risks faced by workers but also raises questions about the sustainability and ethics of fast fashion, making it a critical issue for consumers and policymakers alike.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Oncoinvent reports promising results for cancer treatment Radspherin
PositiveFinancial Markets
Oncoinvent has announced promising results for its cancer treatment, Radspherin, which could significantly improve patient outcomes. This development is crucial as it highlights advancements in cancer therapies, offering hope to patients and families affected by this disease.
Oncoinvent reports promising results for cancer treatment Radspherin
PositiveFinancial Markets
Oncoinvent has announced promising results for its cancer treatment, Radspherin, which could significantly improve patient outcomes. This development is crucial as it highlights advancements in cancer therapies, offering hope to patients and families affected by this disease.
Johnson & Johnson ordered to pay $966 million in talc cancer case after jury finds company liable
NegativeFinancial Markets
In a significant legal ruling, Johnson & Johnson has been ordered to pay $966 million after a jury found the company liable in a talc cancer case. This decision highlights the ongoing concerns surrounding the safety of talcum powder products and their potential link to cancer, affecting countless consumers and raising questions about corporate responsibility. The outcome of this case could set a precedent for future lawsuits and impact the company's reputation and financial standing.
Johnson & Johnson ordered to pay $966 million in talc cancer case after jury finds company liable
NegativeFinancial Markets
In a significant legal ruling, Johnson & Johnson has been ordered to pay $966 million after a jury found the company liable in a talc cancer case. This decision highlights the ongoing concerns surrounding the safety of talcum powder products and their potential link to cancer, affecting countless consumers and raising questions about corporate responsibility. The outcome of this case could set a precedent for future lawsuits and impact the company's reputation and financial standing.
Kazia Therapeutics signs deal for novel cancer immunotherapy asset
PositiveFinancial Markets
Kazia Therapeutics has signed a significant deal to acquire a novel cancer immunotherapy asset, marking a promising step forward in their mission to combat cancer. This partnership not only enhances Kazia's portfolio but also reflects the growing interest and investment in innovative cancer treatments. The deal is expected to accelerate the development of new therapies, potentially offering hope to patients and advancing the field of oncology.
Kazia Therapeutics signs deal for novel cancer immunotherapy asset
PositiveFinancial Markets
Kazia Therapeutics has signed a significant deal to acquire a novel cancer immunotherapy asset, marking a promising step forward in their mission to combat cancer. This partnership not only enhances Kazia's portfolio but also reflects the growing interest and investment in innovative cancer treatments. The deal is expected to accelerate the development of new therapies, potentially offering hope to patients and advancing the field of oncology.
Telomir-1 shows promise in reactivating tumor suppressor genes
PositiveFinancial Markets
Recent studies on telomir-1 have shown promising results in reactivating tumor suppressor genes, which could lead to new therapies for cancer treatment. This breakthrough is significant as it opens up potential avenues for combating various types of cancer, offering hope to patients and researchers alike.
Telomir-1 shows promise in reactivating tumor suppressor genes
PositiveFinancial Markets
Recent studies on telomir-1 have shown promising results in reactivating tumor suppressor genes, which could lead to new therapies for cancer treatment. This breakthrough is significant as it opens up potential avenues for combating various types of cancer, offering hope to patients and researchers alike.
Jefferies raises Nanobiotix stock price target to EUR21.00 on broad cancer potential
PositiveFinancial Markets
Jefferies has raised its price target for Nanobiotix to EUR 21.00, highlighting the company's broad potential in cancer treatment. This adjustment reflects growing confidence in Nanobiotix's innovative approaches to oncology, which could significantly impact patient care and the market. Investors and stakeholders should take note, as this could signal a promising future for the company and its contributions to cancer therapies.
Jefferies raises Nanobiotix stock price target to EUR21.00 on broad cancer potential
PositiveFinancial Markets
Jefferies has raised its price target for Nanobiotix to EUR 21.00, highlighting the company's broad potential in cancer treatment. This adjustment reflects growing confidence in Nanobiotix's innovative approaches to oncology, which could significantly impact patient care and the market. Investors and stakeholders should take note, as this could signal a promising future for the company and its contributions to cancer therapies.
Latest from Financial Markets
Millrose Properties stock initiated at Market Outperform by Citizens
PositiveFinancial Markets
Millrose Properties has received a positive boost as Citizens has initiated coverage on its stock with a 'Market Outperform' rating. This is significant because it suggests that analysts believe Millrose Properties is poised for growth and could outperform the market, which may attract more investors and increase confidence in the company's future.
JPMorgan upgrades Ionis Pharmaceuticals stock to Overweight on pipeline progress
PositiveFinancial Markets
JPMorgan has upgraded Ionis Pharmaceuticals' stock to 'Overweight' due to promising developments in its pipeline. This upgrade reflects confidence in the company's potential to deliver innovative therapies, which could significantly impact the market and investors' portfolios. As Ionis continues to advance its research and development efforts, this positive outlook may attract more attention from investors looking for growth opportunities in the biotech sector.
Jefferies upgrades BOK Financial stock rating to Buy on strong regional growth
PositiveFinancial Markets
Jefferies has upgraded BOK Financial's stock rating to 'Buy', highlighting the company's strong regional growth. This upgrade is significant as it reflects confidence in BOK Financial's performance and potential for future success, which could attract more investors and positively impact the stock market.
HSBC downgrades Intel stock to Reduce despite recent investments
NegativeFinancial Markets
HSBC has downgraded Intel's stock rating to 'Reduce' despite the company's recent investments aimed at boosting its market position. This decision reflects concerns about Intel's ability to compete effectively in a rapidly evolving tech landscape. Investors should take note, as this downgrade could influence market perceptions and stock performance moving forward.
Gold soars above $4,000 an ounce; FOMC minutes ahead - what’s moving markets
PositiveFinancial Markets
Gold prices have surged above $4,000 an ounce, signaling a strong demand for the precious metal amid economic uncertainties. This rise is significant as it reflects investors' confidence in gold as a safe haven during turbulent times. With the FOMC minutes set to be released soon, market watchers are keen to see how monetary policy might influence future gold prices and overall market trends.
AI fintech Optasia aims to raise $375 million in South African listing
PositiveFinancial Markets
AI fintech company Optasia is making headlines as it plans to raise $375 million through a listing in South Africa. This move is significant not only for the company but also for the South African financial landscape, as it highlights the growing interest in fintech solutions powered by artificial intelligence. With this funding, Optasia aims to expand its services and enhance financial accessibility for consumers, potentially transforming the way people manage their finances in the region.